Search Results - "Littow, Harri J"

Blood-Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study by Kuitunen, Hanne K, Rönkä, Aino L K, Sonkajärvi, Eila M, Isokangas, Juha-Matti, Pyörälä, Marja, Palosaari, Kari A A, Jokimäki, Anna S, Partanen, Anu E, Littow, Harri J, Vakkala, Merja A, Jantunen, Esa J, Huttunen, Mirja E, Marin, Katja J, Aromaa-Häyhä, Annikki M K, Auvinen, Päivi K, Selander, Tuomas, Puhakka, Inka K, Kuittinen, Outi M

“…Primary central nervous system lymphoma is a rare but aggressive brain malignancy. It is associated with poor prognosis even with the current standard of care…”
Get full text

Blood–Brain Barrier Disruption , Early Results of a Phase II Study by Kuitunen, Hanne K, Rönkä, Aino L. K, Sonkajärvi, Eila M, Isokangas, Juha-Matti, Pyörälä, Marja, Palosaari, Kari A. A, Jokimäki, Anna S, Partanen, Anu E, Littow, Harri J, Vakkala, Merja A, Jantunen, Esa J, Huttunen, Mirja E, Marin, Katja J, Aromaa-Häyhä, Annikki M. K, Auvinen, Päivi K, Selander, Tuomas, Puhakka, Inka K, Kuittinen, Outi M

“…We present the results of a prospective trial of systemic chemoimmunotherapy for primary CNS lymphoma including the intra-arterial administration of…”
Get full text